Clinical trial Recruiting at 1 site Interventional Ages 50 and up Women only

Comparing two surgical methods for pelvic organ prolapse repair

Official title: Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS

Run by Charles University, Czech Republic · NCT05602246 · Data updated 2026-11-12

This study is testing two different surgical methods to see which one works better for women over 50 with pelvic organ prolapse.

Quick facts

Study typeInterventional
Ages50 Years and up
SexWomen only
Enrollment592 (estimated)
SponsorCharles University, Czech Republic
Academic / other
Locations8 sites (Hradec Králové and 7 other locations)
StatusRecruiting
StartedDecember 1, 2022
Main results expectedNovember 1, 2029
Study endsNovember 1, 2034
Registry record updatedMarch 19, 2026
Trial IDNCT05602246 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 50 and older with at least a second stage prolapse of the anterior compartment and experiencing symptoms of bulge.

Probably not a fit

Patients with malignancy or those unable to communicate in Czech or English may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the efficacy and safety of transobturator cystocele repair (TOCR) with traditional anterior colporrhaphy for treating pelvic organ prolapse, specifically focusing on anterior compartment defects. The study involves women aged 50 and older who experience symptomatic bulge due to at least a second stage prolapse. By assessing the outcomes of these two surgical techniques, the trial seeks to optimize surgical planning and improve patient quality of life. The research is conducted in multiple locations in the Czech Republic, ensuring a diverse patient population.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and quality of life for women suffering from pelvic organ prolapse.

How similar studies have gone: Other studies have shown success with similar surgical approaches, but the specific comparison of TOCR to anterior colporrhaphy is a novel focus.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (at least) 2nd stage prolapse of the anterior compartment (Ba ≥ -1)
* Age ≥ 50 years
* Symptom bulge
* Ability to speak Czech or English

Exclusion Criteria:

* Malignancy

Where it's running

  • Faculty of Medicine in Pilsen, Charles University
    Pilsen, Czechia
    Recruiting
  • Faculty of Medicine in Hradec Kralove, Charles University
    Hradec Králové, Czechia
    Not yet recruiting
  • Medical Faculty, Ostrava University
    Ostrava-Poruba, Czechia
    Not yet recruiting
  • Hospital Pardubice Region, Inc.
    Pardubice, Czechia
    Not yet recruiting
  • Hospital na Bulovce, 1st Medical Faculty, Charles University
    Prague, Czechia
    Not yet recruiting
  • Tomas Bata Regional Hospital in Zlin
    Zlín, Czechia
    Not yet recruiting
Show 2 more locations
  • Košice Medical University
    Košice, Slovakia
    Not yet recruiting
  • Trenčianska univerzita Alexandra Dubčeka
    Trenčín, Slovakia
    Not yet recruiting

Study contacts

  • Principal investigator: Zdenek Rusavy, assoc. prof. MD PhD — Faculty of Medicine in Plzen, Charles University
  • Study coordinator: Vladimir Kalis, prof. MD PhD
  • Email: kalisv@fnplzen.cz
  • Phone: +420377105228

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.